These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 38443674)
21. Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis. Hutten NRPW; Arkell TR; Vinckenbosch F; Schepers J; Kevin RC; Theunissen EL; Kuypers KPC; McGregor IS; Ramaekers JG Psychopharmacology (Berl); 2022 Nov; 239(11):3731-3741. PubMed ID: 36227352 [TBL] [Abstract][Full Text] [Related]
22. Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids. Hindelang P; Scharinger A; Richling E; Walch SG; Lachenmeier DW Front Biosci (Landmark Ed); 2022 Jul; 27(8):228. PubMed ID: 36042166 [TBL] [Abstract][Full Text] [Related]
23. Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations. Moore CF; Weerts EM Psychopharmacology (Berl); 2022 May; 239(5):1397-1408. PubMed ID: 34652500 [TBL] [Abstract][Full Text] [Related]
24. Effects of Δ⁹-tetrahydrocannabinol (THC), cannabidiol (CBD), and THC/CBD mixtures on fentanyl versus food choice in rhesus monkeys. Carey LM; Maguire DR; France CP Drug Alcohol Depend; 2023 Mar; 244():109787. PubMed ID: 36753805 [TBL] [Abstract][Full Text] [Related]
25. Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users. Spindle TR; Cone EJ; Goffi E; Weerts EM; Mitchell JM; Winecker RE; Bigelow GE; Flegel RR; Vandrey R Drug Alcohol Depend; 2020 Jun; 211():107937. PubMed ID: 32247649 [TBL] [Abstract][Full Text] [Related]
26. Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15. Niesink RJ; Rigter S; Koeter MW; Brunt TM Addiction; 2015 Dec; 110(12):1941-50. PubMed ID: 26234170 [TBL] [Abstract][Full Text] [Related]
27. Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract. Nadulski T; Pragst F; Weinberg G; Roser P; Schnelle M; Fronk EM; Stadelmann AM Ther Drug Monit; 2005 Dec; 27(6):799-810. PubMed ID: 16306858 [TBL] [Abstract][Full Text] [Related]
28. Comprehensive cannabinoid profiling of acid-treated CBD samples and Δ Huang S; van Beek TA; Claassen FW; Janssen HG; Ma M; Chen B; Zuilhof H; Salentijn GI Food Chem; 2024 May; 440():138187. PubMed ID: 38134831 [TBL] [Abstract][Full Text] [Related]
30. Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts: A Naturalistic Controlled Study. Sainz-Cort A; Jimenez-Garrido D; Muñoz-Marron E; Viejo-Sobera R; Heeroma J; Bouso JC J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):561-570. PubMed ID: 34412109 [TBL] [Abstract][Full Text] [Related]
31. Use of Tetrahydrocannabinol and Cannabidiol Products in the Perioperative Period Around Primary Unilateral Total Hip and Knee Arthroplasty. Runner RP; Luu AN; Nassif NA; Scudday TS; Patel JJ; Barnett SL; Gorab RS J Arthroplasty; 2020 Jun; 35(6S):S138-S143. PubMed ID: 32173619 [TBL] [Abstract][Full Text] [Related]
32. Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration. Karschner EL; Darwin WD; Goodwin RS; Wright S; Huestis MA Clin Chem; 2011 Jan; 57(1):66-75. PubMed ID: 21078841 [TBL] [Abstract][Full Text] [Related]
33. Current Cannabidiol Safety: A Review. Singh C; Rao K; Yadav N; Vashist Y; Chugh P; Bansal N; Minocha N Curr Drug Saf; 2023; 18(4):465-473. PubMed ID: 36056846 [TBL] [Abstract][Full Text] [Related]
34. UHPLC-MS-MS Determination of THC, CBD and Their Metabolites in Whole Blood of Light Cannabis Smokers. Lo Faro AF; Tini A; Gottardi J; Pichini S; Carlier J; Giorgetti R; Busardò FP J Anal Toxicol; 2023 Jan; 46(9):e256-e261. PubMed ID: 36214389 [TBL] [Abstract][Full Text] [Related]
35. Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract. Nadulski T; Sporkert F; Schnelle M; Stadelmann AM; Roser P; Schefter T; Pragst F J Anal Toxicol; 2005; 29(8):782-9. PubMed ID: 16356335 [TBL] [Abstract][Full Text] [Related]
36. THC and CBD in blood samples and seizures in Norway: Does CBD affect THC-induced impairment in apprehended subjects? Havig SM; Høiseth G; Strand MC; Karinen RA; Brochmann GW; Strand DH; Bachs L; Vindenes V Forensic Sci Int; 2017 Jul; 276():12-17. PubMed ID: 28463706 [TBL] [Abstract][Full Text] [Related]
37. Detection of Δ Arkell TR; Kevin RC; Stuart J; Lintzeris N; Haber PS; Ramaekers JG; McGregor IS Drug Test Anal; 2019 Oct; 11(10):1486-1497. PubMed ID: 31442003 [TBL] [Abstract][Full Text] [Related]
38. Determination of cannabinoids in hair: Indicators for illegal vs CBD-rich cannabis use. Casati S; Angeli I; Bergamaschi RF; Ravelli A; Colombo G; Binelli G; Minoli M; Orioli M Forensic Sci Int; 2022 Apr; 333():111237. PubMed ID: 35228140 [TBL] [Abstract][Full Text] [Related]
39. Dissociable effects of cannabis with and without cannabidiol on the human brain's resting-state functional connectivity. Wall MB; Pope R; Freeman TP; Kowalczyk OS; Demetriou L; Mokrysz C; Hindocha C; Lawn W; Bloomfield MA; Freeman AM; Feilding A; Nutt D; Curran HV J Psychopharmacol; 2019 Jul; 33(7):822-830. PubMed ID: 31013455 [TBL] [Abstract][Full Text] [Related]
40. Behavioral Effects of Vaporized Delta-8 Tetrahydrocannabinol, Cannabidiol, and Mixtures in Male Rats. Durbin DJ; King JM; Stairs DJ Cannabis Cannabinoid Res; 2024 Apr; 9(2):601-611. PubMed ID: 36802211 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]